{"id":3223,"date":"2026-10-14T12:41:23","date_gmt":"2026-10-14T16:41:23","guid":{"rendered":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/?page_id=3223"},"modified":"2026-10-14T16:37:35","modified_gmt":"2026-10-14T20:37:35","slug":"benzodiazepine-tapering-guidelines","status":"publish","type":"page","link":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/benzodiazepine-tapering-guidelines\/","title":{"rendered":"Benzodiazepine Tapering Guidelines"},"content":{"rendered":"<div class=\"gb-container gb-container-9d9a14dc contained\">\n<h1 class=\"gb-headline gb-headline-ea903853 gb-headline-text\">Benzodiazepine Tapering Guidelines<\/h1>\n\n<div class=\"gb-grid-wrapper gb-grid-wrapper-22eecd73\">\n<div class=\"gb-grid-column gb-grid-column-67fc2b47\"><div class=\"gb-container gb-container-67fc2b47\">\n\n<h2 class=\"gb-headline gb-headline-0c82bca0 gb-headline-text\">Benzodiazepine tapers should be carefully scheduled with regular check-ins with patients<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Benzodiazepines should never be stopped abruptly. Withdrawal symptoms can be life-threatening, including inducing seizures; tapering is always the best method.<\/p>\n\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-ff285e70\"><div class=\"gb-container gb-container-ff285e70 bg-maize border-radius container-padded\">\n\n<p class=\"gb-headline gb-headline-9967a4b0 gb-headline-text\">Tapering is recommended when a patient has been taking benzodiazepines for more than 4 weeks and more than 3 days per week.<\/p>\n\n<\/div><\/div>\n<\/div>\n<\/div>\n\n<div class=\"gb-container gb-container-0c291247 contained\">\n\n<h2 class=\"gb-headline gb-headline-52872c56 gb-headline-text\">Generally, taper 5 to 10% every 2\u20134 weeks<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Tapering looks different for every patient. It\u2019s important to check in frequently with your patient to determine how they are feeling and adjust the dose as needed.<\/p>\n\n\n\n<a class=\"gb-button gb-button-dd7661b5 gb-button-text default-button\" href=\"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09499-2\">ASAM Guidelines<\/a>\n\n\n<div class=\"gb-grid-wrapper gb-grid-wrapper-936fbe7e\">\n<div class=\"gb-grid-column gb-grid-column-434854ec\"><div class=\"gb-container gb-container-434854ec container-blue-outline\">\n\n<p class=\"wp-block-paragraph\">Tapering should be supported with ongoing management of the primary disorder and use of available non-pharmacological approaches (e.g. CBT).<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>A reasonable starting rate is a 5% to 10% dose reduction every 2 to 4 weeks<\/li>\n\n\n\n<li>Patients on lower doses for shorter durations may tolerate a faster taper.<\/li>\n\n\n\n<li>After assessing response and tolerability of the 5% to 10% dose decrease, faster tapers should not exceed a 25% reduction every 2 weeks, as they are associated with high discontinuation rates. This maximum rate is not recommended unless continued use poses imminent safety concerns.<\/li>\n\n\n\n<li>Those with greater physical dependence may need a slower approach, such as 5% to 10% every 6 to 8 weeks.<\/li>\n<\/ul>\n\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-b51f458d\"><div class=\"gb-container gb-container-b51f458d container-blue-outline\">\n\n<p class=\"wp-block-paragraph\"><strong>EXAMPLE:<\/strong> A patient on long-term benzodiazepines (Diazepam) will take many months to gradually reduce the dose they take \u2013 this slow approach is generally better tolerated.<\/p>\n\n\n\n<table id=\"tablepress-3\" class=\"tablepress tablepress-id-3\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Week<\/th><th class=\"column-2\">Dose 1<\/th><th class=\"column-3\">Dose 2<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\">0<\/td><td class=\"column-2\">30mg<\/td><td class=\"column-3\">30mg<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\">1-2<\/td><td class=\"column-2\">30mg<\/td><td class=\"column-3\">25mg<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\">3-4<\/td><td class=\"column-2\">25mg<\/td><td class=\"column-3\">25mg<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\">5-6<\/td><td class=\"column-2\">25mg<\/td><td class=\"column-3\">20mg<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\">7-8<\/td><td class=\"column-2\">20mg<\/td><td class=\"column-3\">20mg<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\">9-10<\/td><td class=\"column-2\">20mg<\/td><td class=\"column-3\">15mg<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\">11-12<\/td><td class=\"column-2\">15mg<\/td><td class=\"column-3\">15mg<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\">13-14<\/td><td class=\"column-2\">15mg<\/td><td class=\"column-3\">10mg<\/td>\n<\/tr>\n<tr class=\"row-10\">\n\t<td class=\"column-1\">15-16<\/td><td class=\"column-2\">10mg<\/td><td class=\"column-3\">10mg<\/td>\n<\/tr>\n<tr class=\"row-11\">\n\t<td class=\"column-1\">17-18<\/td><td class=\"column-2\">10mg<\/td><td class=\"column-3\">5mg<\/td>\n<\/tr>\n<tr class=\"row-12\">\n\t<td class=\"column-1\">19-20<\/td><td class=\"column-2\">5mg<\/td><td class=\"column-3\">5mg<\/td>\n<\/tr>\n<tr class=\"row-13\">\n\t<td class=\"column-1\">21-22<\/td><td class=\"column-2\">5mg<\/td><td class=\"column-3\">2.5mg<\/td>\n<\/tr>\n<tr class=\"row-14\">\n\t<td class=\"column-1\">23-24<\/td><td class=\"column-2\">2.5mg<\/td><td class=\"column-3\">2.5mg<\/td>\n<\/tr>\n<tr class=\"row-15\">\n\t<td class=\"column-1\">25<\/td><td class=\"column-2\">25.mg<\/td><td class=\"column-3\">&#8211;<\/td>\n<\/tr>\n<tr class=\"row-16\">\n\t<td class=\"column-1\">26<\/td><td class=\"column-2\">&#8211;<\/td><td class=\"column-3\">&#8211;<\/td>\n<\/tr>\n<tr class=\"row-17\">\n\t<td class=\"column-1\">27<\/td><td class=\"column-2\">&#8211;<\/td><td class=\"column-3\">&#8211;<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-3 from cache -->\n<\/div><\/div>\n<\/div>\n<\/div>\n\n<div class=\"gb-container gb-container-6d727dab contained\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-9a9c4dd3\">\n<div class=\"gb-grid-column gb-grid-column-798c88d6\"><div class=\"gb-container gb-container-798c88d6 rounded-block bg-gray\">\n\n<h2 class=\"gb-headline gb-headline-f84bd932 gb-headline-text\">Filters<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Selecting filters will auto-adjust the list.<\/p>\n\n\n<div class=\"facetwp-facet facetwp-facet-resource_type facetwp-type-checkboxes\" data-name=\"resource_type\" data-type=\"checkboxes\"><\/div>\n\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-119e2de8\"><div class=\"gb-container gb-container-119e2de8\">\n<div class=\"facetwp-facet facetwp-facet-number_of_results facetwp-type-pager\" data-name=\"number_of_results\" data-type=\"pager\"><\/div>\n\n\n\n<p class=\"gb-headline gb-headline-fe5e361f gb-headline-text\">Type at least three characters, and the list will auto-filter.<\/p>\n\n\n<div class=\"facetwp-facet facetwp-facet-text_search facetwp-type-search\" data-name=\"text_search\" data-type=\"search\"><\/div>\n\n\n<div class=\"facetwp-facet facetwp-facet-audience facetwp-type-radio\" data-name=\"audience\" data-type=\"radio\"><\/div>\n\n\n<div class=\"gb-grid-wrapper gb-grid-wrapper-a1afc7ae\">\n<div class=\"gb-grid-column gb-grid-column-2fc23986\"><div class=\"gb-container gb-container-2fc23986\">\n<div class=\"facetwp-selections\"><\/div>\n\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-4d3bcf68\"><div class=\"gb-container gb-container-4d3bcf68 reset-container\">\n<div class=\"facetwp-facet facetwp-facet-reset facetwp-type-reset\" data-name=\"reset\" data-type=\"reset\"><\/div>\n\n<\/div><\/div>\n<\/div>\n\n<div class=\"gb-grid-wrapper gb-grid-wrapper-e0086e35\">\n<div class=\"gb-grid-column gb-grid-column-10e49984\"><div class=\"gb-container gb-container-10e49984\">\n\n\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-61663e47\"><div class=\"gb-container gb-container-61663e47 pager-col\">\n<div class=\"facetwp-facet facetwp-facet-pager_ facetwp-type-pager\" data-name=\"pager_\" data-type=\"pager\"><\/div>\n\n<\/div><\/div>\n<\/div>\n\n\n<div class=\"gb-grid-wrapper gb-grid-wrapper-4ac29783 facetwp-template gb-query-loop-wrapper\">\n<div class=\"gb-grid-column gb-grid-column-1ebeda1b gb-query-loop-item post-3377 resource type-resource status-publish has-post-thumbnail hentry category-benzodiazopine-toolkit-tapering-deprescribing audience-patient resource-type-patient-handouts\"><div class=\"gb-container gb-container-1ebeda1b\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-592de2a0\">\n<div class=\"gb-grid-column gb-grid-column-9d26c57f\"><div class=\"gb-container gb-container-9d26c57f\">\n<figure class=\"gb-block-image gb-block-image-01619eee\"><img loading=\"lazy\" decoding=\"async\" width=\"1307\" height=\"871\" src=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-zdrugs.png\" class=\"gb-image-01619eee\" alt=\"\" srcset=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-zdrugs.png 1307w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-zdrugs-300x200.png 300w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-zdrugs-1024x682.png 1024w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-zdrugs-768x512.png 768w\" sizes=\"auto, (max-width: 1307px) 100vw, 1307px\" \/><\/figure>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-4ea57abd\"><div class=\"gb-container gb-container-4ea57abd\">\n\n\n<h2 class=\"gb-headline gb-headline-4b568ffa gb-headline-text type-loop-title\"><a href=\"https:\/\/deprescribing.org\/wp-content\/uploads\/2018\/08\/Deprescribing-focus-on-BZRAs-FINAL-August2018_CC.pdf\">Deprescribing: Reducing Medications Safely to Meet Life&#8217;s Changes Focus On Benzodiazepine Receptor Agonists &#038; Z-Drugs (BZRAs)<\/a><\/h2>\n\n<p class=\"gb-headline gb-headline-d44cdde1 gb-headline-text type-loop-excerpt\">One pager that can be given to a patient as part of a deprescribing conversation.<\/p>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-08af5232\"><div class=\"gb-container gb-container-08af5232\">\n<p class=\"gb-headline gb-headline-2d03cf3e gb-headline-text term-wrapper\"><span class=\"post-term-item term-benzodiazopine-toolkit-tapering-deprescribing\">Benzodiazopine Toolkit-Tapering\/Deprescribing<\/span><\/p>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-1ebeda1b gb-query-loop-item post-3378 resource type-resource status-publish has-post-thumbnail hentry category-benzodiazopine-toolkit-tapering-deprescribing audience-patient resource-type-patient-handouts resource-type-provider-and-resource-directory resource-type-web-page\"><div class=\"gb-container gb-container-1ebeda1b\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-592de2a0\">\n<div class=\"gb-grid-column gb-grid-column-9d26c57f\"><div class=\"gb-container gb-container-9d26c57f\">\n<figure class=\"gb-block-image gb-block-image-01619eee\"><img loading=\"lazy\" decoding=\"async\" width=\"2533\" height=\"1257\" src=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-cmapatient.png\" class=\"gb-image-01619eee\" alt=\"\" srcset=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-cmapatient.png 2533w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-cmapatient-300x149.png 300w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-cmapatient-1024x508.png 1024w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-cmapatient-768x381.png 768w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-cmapatient-1536x762.png 1536w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-cmapatient-2048x1016.png 2048w\" sizes=\"auto, (max-width: 2533px) 100vw, 2533px\" \/><\/figure>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-4ea57abd\"><div class=\"gb-container gb-container-4ea57abd\">\n\n\n<h2 class=\"gb-headline gb-headline-4b568ffa gb-headline-text type-loop-title\"><a href=\"https:\/\/www.deprescribingnetwork.ca\/patients-and-public\">The Canadian Medication Appropriateness and Deprescribing Network: Resources for patients and the general public.<\/a><\/h2>\n\n<p class=\"gb-headline gb-headline-d44cdde1 gb-headline-text type-loop-excerpt\">A variety of resources for patients and the general public on best prescribing and deprescribing practices, along with medication-related injury prevention.<\/p>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-08af5232\"><div class=\"gb-container gb-container-08af5232\">\n<p class=\"gb-headline gb-headline-2d03cf3e gb-headline-text term-wrapper\"><span class=\"post-term-item term-benzodiazopine-toolkit-tapering-deprescribing\">Benzodiazopine Toolkit-Tapering\/Deprescribing<\/span><\/p>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-1ebeda1b gb-query-loop-item post-3379 resource type-resource status-publish has-post-thumbnail hentry category-benzodiazopine-toolkit-tapering-deprescribing audience-patient resource-type-patient-handouts\"><div class=\"gb-container gb-container-1ebeda1b\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-592de2a0\">\n<div class=\"gb-grid-column gb-grid-column-9d26c57f\"><div class=\"gb-container gb-container-9d26c57f\">\n<figure class=\"gb-block-image gb-block-image-01619eee\"><img loading=\"lazy\" decoding=\"async\" width=\"1630\" height=\"1106\" src=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-patient.png\" class=\"gb-image-01619eee\" alt=\"\" srcset=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-patient.png 1630w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-patient-300x204.png 300w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-patient-1024x695.png 1024w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-patient-768x521.png 768w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-patient-1536x1042.png 1536w\" sizes=\"auto, (max-width: 1630px) 100vw, 1630px\" \/><\/figure>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-4ea57abd\"><div class=\"gb-container gb-container-4ea57abd\">\n\n\n<h2 class=\"gb-headline gb-headline-4b568ffa gb-headline-text type-loop-title\"><a href=\"https:\/\/www.oregon.gov\/oha\/HPA\/DSI-Pharmacy\/MHCAGDocs\/Final-Patient-guide-benzodiazepines-5.13.2022.pdf\">Oregon Health Authority: Patient Guide to Benzodiazepines &#038; Tapering<\/a><\/h2>\n\n<p class=\"gb-headline gb-headline-d44cdde1 gb-headline-text type-loop-excerpt\">This resource provides information to patients on what benzodiazepines are, side effects, dependence, alternate treatments methods, and tapering best practices.<\/p>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-08af5232\"><div class=\"gb-container gb-container-08af5232\">\n<p class=\"gb-headline gb-headline-2d03cf3e gb-headline-text term-wrapper\"><span class=\"post-term-item term-benzodiazopine-toolkit-tapering-deprescribing\">Benzodiazopine Toolkit-Tapering\/Deprescribing<\/span><\/p>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-1ebeda1b gb-query-loop-item post-3369 resource type-resource status-publish has-post-thumbnail hentry category-benzodiazopine-toolkit-tapering-deprescribing audience-provider resource-type-provider-handouts\"><div class=\"gb-container gb-container-1ebeda1b\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-592de2a0\">\n<div class=\"gb-grid-column gb-grid-column-9d26c57f\"><div class=\"gb-container gb-container-9d26c57f\">\n<figure class=\"gb-block-image gb-block-image-01619eee\"><img loading=\"lazy\" decoding=\"async\" width=\"1305\" height=\"1139\" src=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-steps.png\" class=\"gb-image-01619eee\" alt=\"\" srcset=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-steps.png 1305w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-steps-300x262.png 300w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-steps-1024x894.png 1024w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-steps-768x670.png 768w\" sizes=\"auto, (max-width: 1305px) 100vw, 1305px\" \/><\/figure>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-4ea57abd\"><div class=\"gb-container gb-container-4ea57abd\">\n\n\n<h2 class=\"gb-headline gb-headline-4b568ffa gb-headline-text type-loop-title\"><a href=\"https:\/\/www.oregon.gov\/oha\/HPA\/DSI-Pharmacy\/MHCAGDocs\/tapering-benzodiazepines.pdf\">Oregon Health Authority: How To Approach A  Benzodiazepine Taper<\/a><\/h2>\n\n<p class=\"gb-headline gb-headline-d44cdde1 gb-headline-text type-loop-excerpt\">Updated in 2022, this resource includes a step by step guide to tapering, how to convert the patient to diazepam, detailed schedules, and how to manage withdrawal symptoms.<\/p>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-08af5232\"><div class=\"gb-container gb-container-08af5232\">\n<p class=\"gb-headline gb-headline-2d03cf3e gb-headline-text term-wrapper\"><span class=\"post-term-item term-benzodiazopine-toolkit-tapering-deprescribing\">Benzodiazopine Toolkit-Tapering\/Deprescribing<\/span><\/p>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-1ebeda1b gb-query-loop-item post-3370 resource type-resource status-publish has-post-thumbnail hentry category-benzodiazopine-toolkit-tapering-deprescribing audience-provider resource-type-provider-handouts\"><div class=\"gb-container gb-container-1ebeda1b\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-592de2a0\">\n<div class=\"gb-grid-column gb-grid-column-9d26c57f\"><div class=\"gb-container gb-container-9d26c57f\">\n<figure class=\"gb-block-image gb-block-image-01619eee\"><img loading=\"lazy\" decoding=\"async\" width=\"1303\" height=\"1145\" src=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-patcom.png\" class=\"gb-image-01619eee\" alt=\"\" srcset=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-patcom.png 1303w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-patcom-300x264.png 300w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-patcom-1024x900.png 1024w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-patcom-768x675.png 768w\" sizes=\"auto, (max-width: 1303px) 100vw, 1303px\" \/><\/figure>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-4ea57abd\"><div class=\"gb-container gb-container-4ea57abd\">\n\n\n<h2 class=\"gb-headline gb-headline-4b568ffa gb-headline-text type-loop-title\"><a href=\"https:\/\/www.oregon.gov\/oha\/HPA\/DSI-Pharmacy\/MHCAGDocs\/Talking-With-Patients-About-Benzodiazepines.pdf\">Oregon Health Authority: Talking With Your Patient About Deprescribing Benzodiazepines<\/a><\/h2>\n\n<p class=\"gb-headline gb-headline-d44cdde1 gb-headline-text type-loop-excerpt\">A 2 page document to help providers discuss the dangers of benzodiazepine prescriptions and how to taper.<\/p>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-08af5232\"><div class=\"gb-container gb-container-08af5232\">\n<p class=\"gb-headline gb-headline-2d03cf3e gb-headline-text term-wrapper\"><span class=\"post-term-item term-benzodiazopine-toolkit-tapering-deprescribing\">Benzodiazopine Toolkit-Tapering\/Deprescribing<\/span><\/p>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-1ebeda1b gb-query-loop-item post-3371 resource type-resource status-publish has-post-thumbnail hentry category-benzodiazopine-toolkit-tapering-deprescribing audience-patient audience-provider resource-type-continuing-education resource-type-provider-and-resource-directory resource-type-web-page\"><div class=\"gb-container gb-container-1ebeda1b\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-592de2a0\">\n<div class=\"gb-grid-column gb-grid-column-9d26c57f\"><div class=\"gb-container gb-container-9d26c57f\">\n<figure class=\"gb-block-image gb-block-image-01619eee\"><img loading=\"lazy\" decoding=\"async\" width=\"596\" height=\"160\" src=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/deprescribingorg-logo.png\" class=\"gb-image-01619eee\" alt=\"\" srcset=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/deprescribingorg-logo.png 596w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/deprescribingorg-logo-300x81.png 300w\" sizes=\"auto, (max-width: 596px) 100vw, 596px\" \/><\/figure>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-4ea57abd\"><div class=\"gb-container gb-container-4ea57abd\">\n\n\n<h2 class=\"gb-headline gb-headline-4b568ffa gb-headline-text type-loop-title\"><a href=\"https:\/\/deprescribing.org\/\">Deprescribing.org<\/a><\/h2>\n\n<p class=\"gb-headline gb-headline-d44cdde1 gb-headline-text type-loop-excerpt\">This website shares information about deprescribing approaches and deprescribing research with the public, health care providers and researchers. Lots of great resources including: evidence based guidelines, an online learning module &#038; case reports, a deprescribing app for Apple and Android devices, patient-facing one-pagers regarding deprescribing.<\/p>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-08af5232\"><div class=\"gb-container gb-container-08af5232\">\n<p class=\"gb-headline gb-headline-2d03cf3e gb-headline-text term-wrapper\"><span class=\"post-term-item term-benzodiazopine-toolkit-tapering-deprescribing\">Benzodiazopine Toolkit-Tapering\/Deprescribing<\/span><\/p>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-1ebeda1b gb-query-loop-item post-3372 resource type-resource status-publish has-post-thumbnail hentry category-benzodiazopine-toolkit-tapering-deprescribing audience-patient audience-provider resource-type-patient-handouts resource-type-provider-and-resource-directory resource-type-provider-handouts resource-type-web-page\"><div class=\"gb-container gb-container-1ebeda1b\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-592de2a0\">\n<div class=\"gb-grid-column gb-grid-column-9d26c57f\"><div class=\"gb-container gb-container-9d26c57f\">\n<figure class=\"gb-block-image gb-block-image-01619eee\"><img loading=\"lazy\" decoding=\"async\" width=\"276\" height=\"182\" src=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/cmadn-logo.png\" class=\"gb-image-01619eee\" alt=\"\" \/><\/figure>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-4ea57abd\"><div class=\"gb-container gb-container-4ea57abd\">\n\n\n<h2 class=\"gb-headline gb-headline-4b568ffa gb-headline-text type-loop-title\"><a href=\"https:\/\/www.deprescribingnetwork.ca\/\">The Canadian Medication Appropriateness and Deprescribing Network<\/a><\/h2>\n\n<p class=\"gb-headline gb-headline-d44cdde1 gb-headline-text type-loop-excerpt\">This website shares great resources and information about deprescribing approaches.<\/p>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-08af5232\"><div class=\"gb-container gb-container-08af5232\">\n<p class=\"gb-headline gb-headline-2d03cf3e gb-headline-text term-wrapper\"><span class=\"post-term-item term-benzodiazopine-toolkit-tapering-deprescribing\">Benzodiazopine Toolkit-Tapering\/Deprescribing<\/span><\/p>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-1ebeda1b gb-query-loop-item post-3373 resource type-resource status-publish has-post-thumbnail hentry category-benzodiazopine-toolkit-tapering-deprescribing audience-provider resource-type-continuing-education resource-type-peer-reviewed-article\"><div class=\"gb-container gb-container-1ebeda1b\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-592de2a0\">\n<div class=\"gb-grid-column gb-grid-column-9d26c57f\"><div class=\"gb-container gb-container-9d26c57f\">\n<figure class=\"gb-block-image gb-block-image-01619eee\"><img loading=\"lazy\" decoding=\"async\" width=\"1222\" height=\"972\" src=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-mcgeetal.png\" class=\"gb-image-01619eee\" alt=\"\" srcset=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-mcgeetal.png 1222w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-mcgeetal-300x239.png 300w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-mcgeetal-1024x815.png 1024w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-mcgeetal-768x611.png 768w\" sizes=\"auto, (max-width: 1222px) 100vw, 1222px\" \/><\/figure>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-4ea57abd\"><div class=\"gb-container gb-container-4ea57abd\">\n\n\n<h2 class=\"gb-headline gb-headline-4b568ffa gb-headline-text type-loop-title\"><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1555415520304396?casa_token=M4Mcijjip0oAAAAA:z-0LapQSxvrr8vdJDGNWSnRh7fRwBwGOLzc5D6wSkeDW3Wl05z2rdFMswcJQi5zTxk-5SMg\">Reconsidering Benzodiazepines And Z-Drug Prescriptions: Responsible Prescribing And Deprescribing.<\/a><\/h2>\n\n<p class=\"gb-headline gb-headline-d44cdde1 gb-headline-text type-loop-excerpt\">This review aims to increase understanding among NPs working in primary care settings of the history and hazards of hypnotic drugs and, therefore, empower them to influence policy on safe prescribing of hypnotics and to implement deprescribing guidelines in clinical practice.<\/p>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-08af5232\"><div class=\"gb-container gb-container-08af5232\">\n<p class=\"gb-headline gb-headline-2d03cf3e gb-headline-text term-wrapper\"><span class=\"post-term-item term-benzodiazopine-toolkit-tapering-deprescribing\">Benzodiazopine Toolkit-Tapering\/Deprescribing<\/span><\/p>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-1ebeda1b gb-query-loop-item post-3374 resource type-resource status-publish has-post-thumbnail hentry category-benzodiazopine-toolkit-tapering-deprescribing audience-provider resource-type-peer-reviewed-article\"><div class=\"gb-container gb-container-1ebeda1b\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-592de2a0\">\n<div class=\"gb-grid-column gb-grid-column-9d26c57f\"><div class=\"gb-container gb-container-9d26c57f\">\n<figure class=\"gb-block-image gb-block-image-01619eee\"><img loading=\"lazy\" decoding=\"async\" width=\"1508\" height=\"1003\" src=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-pottietal.png\" class=\"gb-image-01619eee\" alt=\"\" srcset=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-pottietal.png 1508w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-pottietal-300x200.png 300w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-pottietal-1024x681.png 1024w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-pottietal-768x511.png 768w\" sizes=\"auto, (max-width: 1508px) 100vw, 1508px\" \/><\/figure>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-4ea57abd\"><div class=\"gb-container gb-container-4ea57abd\">\n\n\n<h2 class=\"gb-headline gb-headline-4b568ffa gb-headline-text type-loop-title\"><a href=\"https:\/\/providerconnect.ca\/Carriers\/GreenShield\/DeprescribePDF\/en_CA\/(CFP)D1.PDF\">Deprescribing Benzodiazepine Receptor Agonists<\/a><\/h2>\n\n<p class=\"gb-headline gb-headline-d44cdde1 gb-headline-text type-loop-excerpt\">This systematic review provides an evidence-based guideline to help clinicians make decisions about when and how to safely taper and stop benzodiazepine receptor agonists (BZRAs). It also focuses on the highest level of evidence available and seeks input from primary care professionals in the guideline development, review, and endorsement processes.<\/p>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-08af5232\"><div class=\"gb-container gb-container-08af5232\">\n<p class=\"gb-headline gb-headline-2d03cf3e gb-headline-text term-wrapper\"><span class=\"post-term-item term-benzodiazopine-toolkit-tapering-deprescribing\">Benzodiazopine Toolkit-Tapering\/Deprescribing<\/span><\/p>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-1ebeda1b gb-query-loop-item post-3375 resource type-resource status-publish has-post-thumbnail hentry category-benzodiazopine-toolkit-tapering-deprescribing audience-provider resource-type-peer-reviewed-article\"><div class=\"gb-container gb-container-1ebeda1b\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-592de2a0\">\n<div class=\"gb-grid-column gb-grid-column-9d26c57f\"><div class=\"gb-container gb-container-9d26c57f\">\n<figure class=\"gb-block-image gb-block-image-01619eee\"><img loading=\"lazy\" decoding=\"async\" width=\"1407\" height=\"1126\" src=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-reidetal.png\" class=\"gb-image-01619eee\" alt=\"\" srcset=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-reidetal.png 1407w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-reidetal-300x240.png 300w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-reidetal-1024x819.png 1024w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-reidetal-768x615.png 768w\" sizes=\"auto, (max-width: 1407px) 100vw, 1407px\" \/><\/figure>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-4ea57abd\"><div class=\"gb-container gb-container-4ea57abd\">\n\n\n<h2 class=\"gb-headline gb-headline-4b568ffa gb-headline-text type-loop-title\"><a href=\"https:\/\/journals.sagepub.com\/doi\/full\/10.1177\/20451253221082386\">Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey<\/a><\/h2>\n\n<p class=\"gb-headline gb-headline-d44cdde1 gb-headline-text type-loop-excerpt\">This article observes the experiences of those who have used, tapered, or discontinued using benzodiazepines via online survey, looking at information such as long-term use, tapering, discontinuation, and withdrawal symptoms.<\/p>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-08af5232\"><div class=\"gb-container gb-container-08af5232\">\n<p class=\"gb-headline gb-headline-2d03cf3e gb-headline-text term-wrapper\"><span class=\"post-term-item term-benzodiazopine-toolkit-tapering-deprescribing\">Benzodiazopine Toolkit-Tapering\/Deprescribing<\/span><\/p>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-1ebeda1b gb-query-loop-item post-3376 resource type-resource status-publish has-post-thumbnail hentry category-benzodiazopine-toolkit-tapering-deprescribing audience-provider resource-type-provider-handouts\"><div class=\"gb-container gb-container-1ebeda1b\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-592de2a0\">\n<div class=\"gb-grid-column gb-grid-column-9d26c57f\"><div class=\"gb-container gb-container-9d26c57f\">\n<figure class=\"gb-block-image gb-block-image-01619eee\"><img loading=\"lazy\" decoding=\"async\" width=\"814\" height=\"1055\" src=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-va.png\" class=\"gb-image-01619eee\" alt=\"\" srcset=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-va.png 814w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-va-231x300.png 231w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-va-790x1024.png 790w, https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2026\/10\/dtap-va-768x995.png 768w\" sizes=\"auto, (max-width: 814px) 100vw, 814px\" \/><\/figure>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-4ea57abd\"><div class=\"gb-container gb-container-4ea57abd\">\n\n\n<h2 class=\"gb-headline gb-headline-4b568ffa gb-headline-text type-loop-title\"><a href=\"https:\/\/www.pbm.va.gov\/PBM\/AcademicDetailingService\/Documents\/Benzodiazepine_Provider_AD_%20Risk_Discussion_Guide.pdf\">Veterans Affairs: Benzodiazepine Risks<\/a><\/h2>\n\n<p class=\"gb-headline gb-headline-d44cdde1 gb-headline-text type-loop-excerpt\">A 2 page guide to help providers discuss the dangers of benzodiazepine prescriptions; there are scripted prompts to start the conversation and a tapering guide for a short (3 month) and long (6 month) taper regimen.<\/p>\n<\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-08af5232\"><div class=\"gb-container gb-container-08af5232\">\n<p class=\"gb-headline gb-headline-2d03cf3e gb-headline-text term-wrapper\"><span class=\"post-term-item term-benzodiazopine-toolkit-tapering-deprescribing\">Benzodiazopine Toolkit-Tapering\/Deprescribing<\/span><\/p>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n<\/div>\n\n\n<div class=\"gb-container gb-container-63b9b32e contained\">\n<div class=\"facetwp-facet facetwp-facet-pager_ facetwp-type-pager\" data-name=\"pager_\" data-type=\"pager\"><\/div>\n\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Benzodiazepine Tapering Guidelines Generally, taper 5 to 10% every 2\u20134 weeks Tapering looks different for every patient. It\u2019s important to check in frequently with your patient to determine how they are feeling and adjust the dose as needed.<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"1","_relevanssi_noindex_reason":"","footnotes":""},"focus-area":[],"class_list":["post-3223","page","type-page","status-publish"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Benzodiazepine Tapering Guidelines - Safer Prescribing Toolkit<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/benzodiazepine-tapering-guidelines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Benzodiazepine Tapering Guidelines - Safer Prescribing Toolkit\" \/>\n<meta property=\"og:description\" content=\"Benzodiazepine Tapering Guidelines Generally, taper 5 to 10% every 2\u20134 weeks Tapering looks different for every patient. It\u2019s important to check in frequently with your patient to determine how they are feeling and adjust the dose as needed.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/benzodiazepine-tapering-guidelines\/\" \/>\n<meta property=\"og:site_name\" content=\"Safer Prescribing Toolkit\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-14T20:37:35+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/injurycenter.umich.edu\\\/safer-prescribing-toolkit\\\/benzodiazepine-tapering-guidelines\\\/\",\"url\":\"https:\\\/\\\/injurycenter.umich.edu\\\/safer-prescribing-toolkit\\\/benzodiazepine-tapering-guidelines\\\/\",\"name\":\"Benzodiazepine Tapering Guidelines - Safer Prescribing Toolkit\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/injurycenter.umich.edu\\\/safer-prescribing-toolkit\\\/#website\"},\"datePublished\":\"2026-10-14T16:41:23+00:00\",\"dateModified\":\"2026-10-14T20:37:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/injurycenter.umich.edu\\\/safer-prescribing-toolkit\\\/benzodiazepine-tapering-guidelines\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/injurycenter.umich.edu\\\/safer-prescribing-toolkit\\\/benzodiazepine-tapering-guidelines\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/injurycenter.umich.edu\\\/safer-prescribing-toolkit\\\/benzodiazepine-tapering-guidelines\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/injurycenter.umich.edu\\\/safer-prescribing-toolkit\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Benzodiazepine Tapering Guidelines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/injurycenter.umich.edu\\\/safer-prescribing-toolkit\\\/#website\",\"url\":\"https:\\\/\\\/injurycenter.umich.edu\\\/safer-prescribing-toolkit\\\/\",\"name\":\"Safer Prescribing Toolkit\",\"description\":\"A comprehensive resource for your clinical practice\",\"publisher\":{\"@id\":\"https:\\\/\\\/injurycenter.umich.edu\\\/safer-prescribing-toolkit\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/injurycenter.umich.edu\\\/safer-prescribing-toolkit\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/injurycenter.umich.edu\\\/safer-prescribing-toolkit\\\/#organization\",\"name\":\"Safer Prescribing Toolkit\",\"url\":\"https:\\\/\\\/injurycenter.umich.edu\\\/safer-prescribing-toolkit\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/injurycenter.umich.edu\\\/safer-prescribing-toolkit\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/injurycenter.umich.edu\\\/safer-prescribing-toolkit\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2024\\\/10\\\/SPT-logo.png\",\"contentUrl\":\"https:\\\/\\\/injurycenter.umich.edu\\\/safer-prescribing-toolkit\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2024\\\/10\\\/SPT-logo.png\",\"width\":3300,\"height\":1200,\"caption\":\"Safer Prescribing Toolkit\"},\"image\":{\"@id\":\"https:\\\/\\\/injurycenter.umich.edu\\\/safer-prescribing-toolkit\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Benzodiazepine Tapering Guidelines - Safer Prescribing Toolkit","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/benzodiazepine-tapering-guidelines\/","og_locale":"en_US","og_type":"article","og_title":"Benzodiazepine Tapering Guidelines - Safer Prescribing Toolkit","og_description":"Benzodiazepine Tapering Guidelines Generally, taper 5 to 10% every 2\u20134 weeks Tapering looks different for every patient. It\u2019s important to check in frequently with your patient to determine how they are feeling and adjust the dose as needed.","og_url":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/benzodiazepine-tapering-guidelines\/","og_site_name":"Safer Prescribing Toolkit","article_modified_time":"2026-10-14T20:37:35+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/benzodiazepine-tapering-guidelines\/","url":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/benzodiazepine-tapering-guidelines\/","name":"Benzodiazepine Tapering Guidelines - Safer Prescribing Toolkit","isPartOf":{"@id":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/#website"},"datePublished":"2026-10-14T16:41:23+00:00","dateModified":"2026-10-14T20:37:35+00:00","breadcrumb":{"@id":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/benzodiazepine-tapering-guidelines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/benzodiazepine-tapering-guidelines\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/benzodiazepine-tapering-guidelines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/"},{"@type":"ListItem","position":2,"name":"Benzodiazepine Tapering Guidelines"}]},{"@type":"WebSite","@id":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/#website","url":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/","name":"Safer Prescribing Toolkit","description":"A comprehensive resource for your clinical practice","publisher":{"@id":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/#organization","name":"Safer Prescribing Toolkit","url":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/#\/schema\/logo\/image\/","url":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2024\/10\/SPT-logo.png","contentUrl":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-content\/uploads\/sites\/2\/2024\/10\/SPT-logo.png","width":3300,"height":1200,"caption":"Safer Prescribing Toolkit"},"image":{"@id":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-json\/wp\/v2\/pages\/3223","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-json\/wp\/v2\/comments?post=3223"}],"version-history":[{"count":5,"href":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-json\/wp\/v2\/pages\/3223\/revisions"}],"predecessor-version":[{"id":3380,"href":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-json\/wp\/v2\/pages\/3223\/revisions\/3380"}],"wp:attachment":[{"href":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-json\/wp\/v2\/media?parent=3223"}],"wp:term":[{"taxonomy":"focus-area","embeddable":true,"href":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/wp-json\/wp\/v2\/focus-area?post=3223"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}